Understanding the contribution of hyperammonemia to infusion reactions is necessary to make decisions about continuing the first-line asparaginase or switching to an alternative asparaginase or infusion protocol to assure the successful completion of all needed asparaginase doses and to maximize event-free survival. This evidence concerns the gene ASPG and Hyperammonemia.